Related Experiment Video

Updated: Mar 17, 2026

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

2.1K

Harnessing immunosurveillance: current developments and future directions in cancer immunotherapy

Maureen L Drakes1, Patrick J Stiff1

  • 1Department of Medicine, Division of Hematology and Oncology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL, USA.

Immunotargets and Therapy
|July 30, 2016
PubMed

Insights

Cancer immunotherapy aims to enhance the immune system against tumors by overcoming immunosuppression. Novel biomarkers and combination therapies are crucial for improving survival in advanced cancer patients.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Research

Background:

  • Cancer remains a significant public health issue despite advances in detection and conventional treatments.
  • Conventional therapies like chemotherapy, radiation, and surgery often fail to prevent cancer recurrence.
  • Novel therapeutic strategies are needed to manage metastatic disease and improve patient survival.

Purpose of the Study:

  • To review protumor mechanisms that evade immune surveillance in cancer patients.
  • To discuss current immunotherapies targeting these immunosuppressive mechanisms.
  • To highlight the role of biomarkers and combination immunotherapy for advanced cancer.

Main Methods:

  • Literature review of protumor mechanisms and immunotherapy modalities.
  • Analysis of current strategies to enhance antitumor immunity.
  • Discussion on the potential of novel biomarkers and combination regimens.

Main Results:

  • Protumor mechanisms effectively circumvent host immunosurveillance in cancer patients.
  • Current immunotherapies aim to target these immunosuppressive pathways.
  • Biomarker discovery and combination immunotherapy approaches show promise.

Conclusions:

  • Targeted immunotherapy development requires identification of novel cancer biomarkers.
  • Combination immunotherapy regimens are essential for improving survival rates in advanced cancer.
  • Modulating the immune system is key to overcoming cancer recurrence and metastasis.
Keywords:
T-cellscancerdendritic cellsimmunosuppressionimmunosurveillanceimmunotherapy

More Related Videos

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.9K
Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors06:32

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

3.2K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.8K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
598
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
811